N-Propionitrile brorphine

N-Propionitrile brorphine
Identifiers
  • 3-[3-[1-[1-(4-Bromophenyl)ethyl]piperidin-4-yl]-2-oxobenzimidazol-1-yl]propanenitrile
Chemical and physical data
FormulaC23H25BrN4O
Molar mass453.384 g·mol−1
3D model (JSmol)
  • CC(C1=CC=C(Br)C=C1)N2CCC(N3C(N(CCC#N)C4=C3C=CC=C4)=O)CC2
  • InChI=InChI=1S/C23H25BrN4O/c1-17(18-7-9-19(24)10-8-18)26-15-11-20(12-16-26)28-22-6-3-2-5-21(22)27(23(28)29)14-4-13-25/h2-3,5-10,17,20H,4,11-12,14-16H2,1H3
  • Key:KKMLKZDRZWLZFT-UHFFFAOYSA-N

N-Propionitrile brorphine (cybrorphine) is a synthetic opioid chemical compound which has been sold as a designer drug, first reported in New York State in April 2026 as a component of mixtures with other opioid or sedative drugs such as fentanyl and medetomidine. Its pharmacology has not yet been studied, but given its close chemical similarity to potent synthetic opioids such as brorphine and cychlorphine, it is expected to have similar effects.[1][2]

See also

References

  1. ↑ "PUBLIC HEALTH ALERT. Drug Checking Programs. New York State Department of Health, 1 July 2026" (PDF). www.health.ny.gov.
  2. ↑ "Synthetic Opioid, N-Propionitrile Brorphine. Office of Addiction Services and Supports 7 July 2026". Office of Addiction Services and Supports.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.